These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33278013)

  • 1. Editorial: Proteins of SARS CoV-2, the Cause of COVID-19, and the Proteins that Interact with Them.
    Yoshimoto FK; Berliner LJ
    Protein J; 2020 Dec; 39(6):599. PubMed ID: 33278013
    [No Abstract]   [Full Text] [Related]  

  • 2. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells.
    Han Q; Wang J; Luo H; Li L; Lu X; Liu A; Deng Y; Jiang Y
    Aging (Albany NY); 2021 Mar; 13(7):9160-9185. PubMed ID: 33744846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.
    Hopp MT; Domingo-Fernández D; Gadiya Y; Detzel MS; Graf R; Schmalohr BF; Kodamullil AT; Imhof D; Hofmann-Apitius M
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
    Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
    Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The known unknowns of T cell immunity to COVID-19.
    Karlsson AC; Humbert M; Buggert M
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms?
    Ong J; Dan YY
    Dig Dis Sci; 2021 Oct; 66(10):3228-3230. PubMed ID: 33428034
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
    Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
    Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection remodels the host protein thermal stability landscape.
    Selkrig J; Stanifer M; Mateus A; Mitosch K; Barrio-Hernandez I; Rettel M; Kim H; Voogdt CGP; Walch P; Kee C; Kurzawa N; Stein F; Potel C; Jarzab A; Kuster B; Bartenschlager R; Boulant S; Beltrao P; Typas A; Savitski MM
    Mol Syst Biol; 2021 Feb; 17(2):e10188. PubMed ID: 33590968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current landscape of coronavirus-host protein-protein interactions.
    Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO
    J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronobiology in response to COVID-19.
    Cermakian N; Harrington ME
    J Biol Rhythms; 2021 Feb; 36(1):3. PubMed ID: 33543668
    [No Abstract]   [Full Text] [Related]  

  • 12. Membrane remodeling and trafficking piloted by SARS-CoV-2.
    Sergio MC; Ricciardi S; Guarino AM; Giaquinto L; De Matteis MA
    Trends Cell Biol; 2024 Sep; 34(9):785-800. PubMed ID: 38262893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis.
    Das JK; Roy S; Guzzi PH
    Infect Genet Evol; 2021 Sep; 93():104921. PubMed ID: 34004362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring G protein-coupled receptors and yeast surface display strategies for viral detection in baker's yeast: SARS-CoV-2 as a case study.
    Maneira C; Bermejo PM; Pereira GAG; de Mello FDSB
    FEMS Yeast Res; 2021 Mar; 21(1):. PubMed ID: 33469649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of SARS-CoV-2 proteins on vascular permeability.
    Rauti R; Shahoha M; Leichtmann-Bardoogo Y; Nasser R; Paz E; Tamir R; Miller V; Babich T; Shaked K; Ehrlich A; Ioannidis K; Nahmias Y; Sharan R; Ashery U; Maoz BM
    Elife; 2021 Oct; 10():. PubMed ID: 34694226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution.
    Ou Z; Ouzounis C; Wang D; Sun W; Li J; Chen W; Marlière P; Danchin A
    Genome Biol Evol; 2020 Dec; 12(12):2467-2485. PubMed ID: 33125064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: Risk Factors Associated with Infectivity and Severity.
    Fadl N; Ali E; Salem TZ
    Scand J Immunol; 2021 Jun; 93(6):e13039. PubMed ID: 33710663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral dynamics in the Upper Respiratory Tract (URT) of SARS-CoV-2.
    Tirupathi R; Ramparas TR; Wadhwa G; Areti S; Kaur J; Salim S; Rabaan AA; Al-Tawfiq JA
    Infez Med; 2020 Dec; 28(4):486-499. PubMed ID: 33257622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and Strategies for Its Therapeutics.
    Ma F; Gu T; Zhao S; Liu K; Dong Z
    Crit Rev Immunol; 2020; 40(6):513-526. PubMed ID: 33900695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.